4
Changes in Ownership
Monopar Therapeutics Filed Acc 0001437749-25-022862
Director sold 16,800 shares at $40.00 ($672,020)
- Director acquired 16,800 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| STARR CHRISTOPHER M Director | 2025-07-14 | Option exercise | +16,800 | $0.01 | $84 | 21,973 | D |
| STARR CHRISTOPHER M Director | 2025-07-14 | Sale | −16,800 | $40.00 | $672,020 | 5,173 | D |
| Derivatives | |||||||
| STARR CHRISTOPHER M Director | 2025-07-14 | Option exercise · Stock Options | −16,800 | 0 | D | ||
| Open-market sales · 16,800 sh · avg $40.00 · $672,020 | |||||||
Loading xslF345X05/rdgdoc.xml…